ONLINE DATABASE SEARCH - HIV-LS-298-MEMO
1. 43529 HIV-LS-298; PUBMED-HIV-6/16/2004
Non-Peptidic HIV Protease Inhibitors
Chrusciel, RA and Strohbach, JW
Curr Top Med Chem 2004. 4(10): 1097-114
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15193141&dopt=abstract
2. 43530 HIV-LS-298; PUBMED-HIV-6/16/2004
Peptidomimetic Inhibitors of HIV Protease
Randolph, JT and DeGoey, DA
Curr Top Med Chem 2004. 4(10): 1079-95
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15193140&dopt=abstract
3. 43531 HIV-LS-298; PUBMED-HIV-6/16/2004
HIV-1 Integrase Inhibitors: A Decade of Research and Two Drugs in Clinical Trial
Johnson, AA, Marchand, C, and Pommier, Y
Curr Top Med Chem 2004. 4(10): 1059-77
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15193139&dopt=abstract
4. 43532 HIV-LS-298; PUBMED-HIV-6/16/2004
Synthesis, Structure-Activity Relationships, and Drug Resistance of beta-d-3'-Fluoro-2',3'-Unsaturated Nucleosides as Anti-HIV Agents
Zhou, W, Gumina, G, Chong, Y, Wang, J, Schinazi, RF, and Chu, CK
J Med Chem 2004. 47(13): 3399-408
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15189036&dopt=abstract
5. 43533 HIV-LS-298; EMBASE-HIV-6/16/2004
HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches
De Clercq, Erik
The International Journal of Biochemistry & Cell Biology 2004. 36(9): 1800-1822
HYPERLINK: http://www.sciencedirect.com/science/article/B6TCH-4CBDBKJ-1/2/1255b5662c1cb233be6baacbadc8220d
6. 43534 HIV-LS-298; PUBMED-HIV-6/16/2004
Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines
Brzozowski, Z, Saczewski, F, Sanchez, T, Kuo, CL, Gdaniec, M, and Neamati, N
Bioorg Med Chem 2004. 12(13): 3663-72
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15186851&dopt=abstract
7. 43535 HIV-LS-298; EMBASE-HIV-6/16/2004
Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia
Mackie, Nicola, Dustan, Simon, McClure, Myra O, Weber, Jonathan N, and Clarke, John R
Journal of Virological Methods 2004. 119(2): 73-78
HYPERLINK: http://www.sciencedirect.com/science/article/B6T96-4C76GN5-2/2/f048012db030a1f2adef5984b4777052
8. 43536 HIV-LS-298; PUBMED-HIV-6/16/2004
Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20
Cilliers, T, Patience, T, Pillay, C, Papathanasopoulos, M, and Morris, L
AIDS Res Hum Retroviruses 2004. 20(5): 477-82
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15186521&dopt=abstract
9. 43537 HIV-LS-298; EMBASE-HIV-6/16/2004
The Stability of the Intact Envelope Glycoproteins is a Major Determinant of Sensitivity of HIV/SIV to Peptidic Fusion Inhibitors
Gallo, Stephen A, Sackett, Kelly, Rawat, Satinder S, Shai, Yechiel, and Blumenthal, Robert
Journal of Molecular Biology 2004. 340(1): 9-14
HYPERLINK: http://www.sciencedirect.com/science/article/B6WK7-4CDG0BR-1/2/91f90c9ad8c7fbad207b50afcc4d5ce5
10. 43538 HIV-LS-298; PUBMED-HIV-6/16/2004
Design and synthesis of novel dihydroxyindole-2-carboxylic acids as HIV-1 integrase inhibitors
Sechi, M, Angotzi, G, Dallocchio, R, Dessi, A, Carta, F, Sannia, L, Mariani, A, Fiori, S, Sanchez, T, Movsessian, L, Plasencia, C, and Neamati, N
Antivir Chem Chemother 2004. 15(2): 67-81
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15185725&dopt=abstract
11. 43539 HIV-LS-298; PUBMED-HIV-6/16/2004
Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2))
Balzarini, J, Andersson, E, Schols, D, Proost, P, Van, Damme J, Svennerholm, B, Horal, P, and Vahlne, A
Int J Biochem Cell Biol 2004. 36(9): 1848-59
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15183349&dopt=abstract
12. 43540 HIV-LS-298; EMBASE-HIV-6/16/2004
New Carbohydrate Specificity and HIV-1 Fusion Blocking Activity of the Cyanobacterial Protein MVL: NMR, ITC and Sedimentation Equilibrium Studies
Bewley, Carole A, Cai, Mengli, Ray, Satyajit, Ghirlando, Rodolfo, Yamaguchi, Masato, and Muramoto, Koji
Journal of Molecular Biology 2004. 339(4): 901-914
HYPERLINK: http://www.sciencedirect.com/science/article/B6WK7-4C8DCM4-1/2/0968718ad542716afd92f3b43fdc5014
13. 43541 HIV-LS-298; PUBMED-HIV-6/16/2004
Effects of HIV-1 entry inhibitors in combination
Tremblay, C
Curr Pharm Des 2004. 10(15): 1861-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15180545&dopt=abstract
14. 43542 HIV-LS-298; PUBMED-HIV-6/16/2004
HIV-resistance to viral entry inhibitors
Menendez-Arias, L and Este, JA
Curr Pharm Des 2004. 10(15): 1845-60
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15180544&dopt=abstract
15. 43543 HIV-LS-298; EMBASE-HIV-6/16/2004
Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation
Dinauer, Norbert, Lochmann, Dirk, Demirhan, Ilhan, Bouazzaoui, Abdellatif, Zimmer, Andreas, Chandra, Angelika, Kreuter, Jorg, and von Briesen, Hagen
Journal of Controlled Release 2004. 96(3): 497-507
HYPERLINK: http://www.sciencedirect.com/science/article/B6T3D-4C52NVY-1/2/a017bf4da34785aee8e22fedab94ab58
16. 43544 HIV-LS-298; PUBMED-HIV-6/16/2004
A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding
Wang, HG, Williams, RE, and Lin, PF
Curr Pharm Des 2004. 10(15): 1785-93
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15180540&dopt=abstract
17. 43545 HIV-LS-298; PUBMED-HIV-6/16/2004
Antiviral Properties of Quinolone-based Drugs
Richter, S, Parolin, C, Palumbo, M, and Palu, G
Curr Drug Targets Infect Disord 2004. 4(2): 111-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15180459&dopt=abstract
18. 43546 HIV-LS-298; PUBMED-HIV-6/16/2004
A novel laccase with fair thermostability from the edible wild mushroom (Albatrella dispansus)
Wang, HX and Ng, TB
Biochem Biophys Res Commun 2004. 319(2): 381-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15178417&dopt=abstract
19. 43547 HIV-LS-298; EMBASE-HIV-6/16/2004
Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA
Zhao, Hong, Li, Jinru, Xi, Fu, and Jiang, Long
FEBS Letters 2004. 563(1-3): 241-245
HYPERLINK: http://www.sciencedirect.com/science/article/B6T36-4BYP29F-G/2/d20f69a56f94363eb417067c01dc3bed
20. 43548 HIV-LS-298; PUBMED-HIV-6/16/2004
Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists
Princen, K, Hatse, S, Vermeire, K, De, Clercq E, and Schols, D
Retrovirology 2004. 1(1): 2
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15169555&dopt=abstract
21. 43549 HIV-LS-298; EMBASE-HIV-6/16/2004
Crucial amides for dimerization inhibitors of HIV-1 protease
Bowman, Michael J and Chmielewski, Jean
Bioorganic & Medicinal Chemistry Letters 2004. 14(6): 1395-1398
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BT8F6G-3/2/dfcc94eb5e99448350e1fc36c4e136a7
22. 43550 HIV-LS-298; PUBMED-HIV-6/16/2004
A new ribonuclease from the black oyster mushroom Pleurotus ostreatus
Wang, HX and Ng, TB
Peptides 2004. 25(4): 685-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15165725&dopt=abstract
23. 43551 HIV-LS-298; EMBASE-HIV-6/16/2004
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA
Mischiati, Carlo, Finotti, Alessia, Sereni, Alessia, Boschetti, Sindi, Baraldi, Pier Giovanni, Romagnoli, Romeo, Feriotto, Giordana, Jeang, Kuan-Teh, Bianchi, Nicoletta, Borgatti, Monica, and Gambari, Roberto
Biochemical Pharmacology 2004. 67(3): 401-410
HYPERLINK: http://www.sciencedirect.com/science/article/B6T4P-4BRCNCP-3/2/f9cf7272f21dd4b21f3558568e53d075
24. 43552 HIV-LS-298; PUBMED-HIV-6/16/2004
Structure-based design, synthesis, and antimicrobial activity of purine derived SAH/MTA nucleosidase inhibitors
Tedder, ME, Nie, Z, Margosiak, S, Chu, S, Feher, VA, Almassy, R, Appelt, K, and Yager, KM
Bioorg Med Chem Lett 2004. 14(12): 3165-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15149667&dopt=abstract
25. 43553 HIV-LS-298; PUBMED-HIV-6/16/2004
Design, synthesis, and evaluation of 5'-S-aminoethyl-N(6)- azidobenzyl-5'-thioadenosine biotin conjugate: a bifunctional photoaffinity probe for the es nucleoside transporter
Addo, JK and Buolamwini, JK
Bioconjug Chem 2004. 15(3): 536-40
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15149181&dopt=abstract
26. 43554 HIV-LS-298; EMBASE-HIV-6/16/2004
Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid)
Zhao, Hong, Li, Jinru, and Jiang, Long
Biochemical and Biophysical Research Communications 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WBK-4CK7STX-5/2/9b474cec37aa7b4b99253f52f5eef670
27. 43555 HIV-LS-298; EMBASE-HIV-6/16/2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor
Shankaran, K, Donnelly, Karla L, Shah, Shrenik K, Guthikonda, Ravindra N, MacCoss, Malcolm, Mills, Sander G, Gould, Sandra L, Malkowitz, Lorraine, Siciliano, Salvatore J, and Springer, Martin S
Bioorganic & Medicinal Chemistry Letters 2004. 14(13): 3419-3424
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CDHFTG-6/2/31c9d689640beb297ec738dd1c752c70
28. 43556 HIV-LS-298; EMBASE-HIV-6/16/2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonists
Shankaran, K, Donnelly, Karla L, Shah, Shrenik K, Caldwell, Charles G, Chen, Ping, Finke, Paul E, Oates, Bryan, MacCoss, Malcolm, Mills, Sander G, and DeMartino, Julie A
Bioorganic & Medicinal Chemistry Letters 2004. 14(13): 3589-3593
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CF5BWW-2/2/d0f7240a135e5f5e1c19dcae1c722417
29. 43557 HIV-LS-298; EMBASE-HIV-6/16/2004
Antiviral activity against human immunodeficiency virus-1 in vitro by myristoylated-peptide from Heliothis virescens
Ourth, Donald D
Biochemical and Biophysical Research Communications 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WBK-4CKNK3F-1/2/272867c18539a322bf4ac7eea6731441
30. 43558 HIV-LS-298; EMBASE-HIV-6/16/2004
Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs
Bailey, Justin, Blankson, Joel N, Wind-Rotolo, Megan, and Siliciano, Robert F
Current Opinion in Immunology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VS1-4CMJ0D5-1/2/84735d93c617d30c21aa62a34dde1652
31. 43559 HIV-LS-298; WOS-HIV-6/6/2004
Mycobacterium tuberculosis - Induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages
Hoshino, Y, Tse, DB, Rochford, G, Prabhakar, S, Hoshino, S, Chitkara, N, Kuwabara, K, Ching, E, Raju, B, Gold, JA, Borkowsky, W, Rom, WN, Pine, R, and Weiden, M
J IMMUNOL 2004. 172(10): 6251-6258
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221276900058
32. 43560 HIV-LS-298; WOS-HIV-6/6/2004
Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity
Bernard, C, Zouhiri, F, Normand-Bayle, M, Danet, M, Desmaele, D, Leh, H, Mouscadet, JF, Mbemba, G, Thomas, CM, Bonnenfant, S, Le, Bret M, and d'Angelo, J
BIOORG MED CHEM LETT 2004. 14(10): 2473-2476
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221316000017
33. 43561 HIV-LS-298; WOS-HIV-6/6/2004
Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea - synthesis and structure-activity relationships
Sham, HL, Betebenner, DA, Rosenbrook, W, Herrin, T, Saldivar, A, Vasavanonda, S, Plattner, JJ, and Norbeck, DW
BIOORG MED CHEM LETT 2004. 14(10): 2643-2645
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221316000051
34. 43562 HIV-LS-298; WOS-HIV-6/6/2004
Synergistic anti-HIV activity of zinc-finger inhibitory molecules used in combination with a variety of other anti-HIV agents
Buckheit, RW, Russell, J, Hartman, TL, Imnan, JK, Schito, M, Goel, A, Appella, E, and Turpin, JA
ANTIVIR RES 2004. 62(2): A27-A28
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800004
35. 43563 HIV-LS-298; WOS-HIV-6/6/2004
Discovery of a novel class of small-molecule HIV entry inhibitors that target the gp120-binding domain of CD4
Yang, Q, Roberts, P, Zhu, W, Stephen, A, Adelsberger, J, Currens, M, Feng, Y, Fisher, R, Rein, A, Shoemaker, R, and Sei, S
ANTIVIR RES 2004. 62(2): A28
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800005
36. 43564 HIV-LS-298; WOS-HIV-6/6/2004
Novel tyrosine derived HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles
Miller, JF, Brieger, M, Furfine, ES, Hazen, RJ, Kaldor, I, and Spaltenstien, A
ANTIVIR RES 2004. 62(2): A41
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800035
37. 43565 HIV-LS-298; WOS-HIV-6/13/2004
Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion
Ling, H, Xiao, P, Usami, O, and Hattori, T
MICROBES INFECT 2004. 6(5): 414-420
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221494200001
38. 43566 HIV-LS-298; WOS-HIV-6/13/2004
Specific reactions between purified HIV-1 particles and CD4(+) cell membrane fragments in a cell-free system of virus fusion or entry
Harada, T, Tatsumi, M, Takahashi, H, Sata, T, Kurata, T, and Kojima, A
MICROBES INFECT 2004. 6(5): 421-428
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221494200002
39. 43567 HIV-LS-298; WOS-HIV-6/13/2004
Interaction of cycloSal-pronucleotides with cholinesterases from different origins. A structure-activity relationship
Meier, C, Ducho, C, Gorbig, U, Esnouf, R, and Balzarini, J
J MED CHEM 2004. 47(11): 2839-2852
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221456700015
40. 43568 HIV-LS-298; WOS-HIV-6/13/2004
The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1
Berkhout, B, Floris, R, Recio, I, and Visser, S
BIOMETALS 2004. 17(3): 291-294
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221392300017